Investor Relations

Stock price graph
     

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

PDF 2013 Annual Report [ 4.4 MB]

Recent Releases

Sep 22, 2014
Exact Sciences Announces Group Health Cooperative as First Health Plan in Wisconsin to Cover Cologuard®

Aug 28, 2014
Exact Sciences to participate in Baird's 2014 Health Care Conference

Aug 25, 2014
Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard®

View all releases »

Stock Quote

Ticker:
EXAS
Exchange:
NASDAQ
Price:
19.38
Change:
+ 0.01
Volume:
1,628,600
4:00 PM ET on Sep 30, 2014
Delayed at least 20 minutes.
Provided by eSignal.

IR Search